GGrantIndex
Sort

15,842 grants matching pancreatic cancer

THE PREVENTION OF B(A)P INDUCED CELL TRANSFORMATION BY ORGANOSULFUR COMPOUNDS

$117,288
Selina Faith Darling-Reed · Florida Agricultural And Mechanical Univ · G12 · FY2009 · RR

Career Development Program

$117,259
Scott E Kern · Johns Hopkins University · P50 · FY2009 · CA

JAK1 Signaling in Pancreatic Cancer Initiation and Progression

$117,233
Kay-Uwe Wagner · University Of Nebraska Medical Center · R01 · FY2018 · CA

Effects of silencing RNAs for gastrin and CCK on human pancreatic cancer

$117,200
Jill P Smith · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2007 · CA

Full Project 3 – Pancreatic ADM

$117,199
Thomas D Schmittgen · University Of Florida · U54 · FY2025 · CA

Tissue Modeling & Drug Development Shared Resources Core

$117,199
Paul Okunieff · University Of Florida · U54 · FY2025 · CA

Pilot Project 5 - Pancreatic Treatment

$117,199
Saunjoo L Yoon · University Of Florida · U54 · FY2025 · CA

Community Outreach Core

$117,198
Fern Jureidini Webb · University Of Florida · U54 · FY2025 · CA

RECEPTORS FOR CCK AND OTHER GI-HORMONES

$117,165
University Of Michigan At Ann Arbor · R01 · FY2004 · DK

CHROMOGRANIN A RELATED PEPTIDES IN THE GUT AND PANCREAS

$117,148
University Of Texas Medical Br Galveston · P01 · FY2000 · DK

Tissue Banks

$116,854
Christine A Iacobuzio-Donahue · Johns Hopkins University · P50 · FY2013 · CA

Role of ErbB/Stat3 in the establishment and progression of pancreatic cancer

$116,800
James Freeman · University Of Texas Hlth Science Center · R21 · FY2007 · CA

Role of Heparan Sulfate-Degrading Sulfatases in Pancreatic Adenocarcinomas

$116,660
Steven D Rosen · University Of California, San Francisco · R21 · FY2006 · CA

Administrative Core

$116,626
Vay Liang W. Go · University Of California Los Angeles · P01 · FY2021 · CA

Functions of the LKB1 tumor suppressor in control in metabolism and epigenetics

$116,466
Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2022 · CA

Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation

$116,400
Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2019 · CA

Role of Fetuin-A in Tumor Cell Growth

$116,398
Josiah Ochieng · Meharry Medical College · SC1 · FY2012 · CA

Elucidating the mechanisms of Glis3-regulated development in the pancreas and kidney

$116,376
Gary T Zeruth · Murray State University · R16 · FY2025 · DK

IGF binding protein-3 in beta cell apoptosis

$116,370
University Of California Los Angeles · K08 · FY2001 · DK

Clinical Investigation in Pancreatic & Biliary Disorders

$116,356
Charles Wilcox · University Of Alabama At Birmingham · K24 · FY2007 · DK

Core 2: Biospecimen/Pathology Core

$116,311
Elizabeth D Thompson · Johns Hopkins University · P50 · FY2021 · CA

Novel Strategies for Precision T-cell Therapies

$116,287
Steven C. Almo · Albert Einstein College Of Medicine · R01 · FY2019 · CA

Regulation of Growth Factor Activity by A2 Macroglobulin

$116,282
University Of Virginia Charlottesville · R01 · FY2001 · CA

The role of EGFR signaling in progression of Kras-induced pacreatic tumors

$116,280
Anna L Means · Vanderbilt University · R21 · FY2006 · CA

Transcriptional control of T cell function during type 1 diabetes

$116,126
Laura Shaw · National Jewish Health · K01 · FY2024 · DK